Officer Jon Congleton Files Intent to Sell $1.96M in MLYS Stock
MLYS has more than doubled off its 52-week low of $12.59.
Summary
An officer of Mineralys Therapeutics, Jon Congleton, has filed a Form 144 indicating an intent to sell approximately $1.96 million worth of common stock. This follows previous sales by the same officer.
Key Events · Ownership and Investor Activity · MLYS
-
Officer Files Intent to Sell
Jon Congleton, an officer of Mineralys Therapeutics, filed a Form 144 to sell 75,000 shares of common stock, valued at approximately $1.96 million.
-
Follows Recent Sales
This filing indicates that Jon Congleton has already sold 90,730 shares for gross proceeds of $2.39 million in the past three months, contributing to a net distribution of $4.3 million from insiders over the last 90 days.
-
Shares from Equity Awards
The shares intended for sale were acquired through the vesting of restricted share unit awards, granted as part of the issuer's equity compensation plan.
Analysis · MLYS · Life Sciences
This Form 144 indicates an officer's intent to liquidate a significant portion of their holdings, following a pattern of sales over the past three months. While the shares originate from equity compensation, the consistent selling by an officer can be interpreted as a lack of conviction in the company's near-term stock performance, especially after a recent $150M stock offering.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MLYS was trading at $26.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $12.59 to $47.65. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.